FDA approves alternative mammography quality assurance program

An alternative digital full-field mammography quality assurance program has been cleared for use nationwide, according to an announcement from the FDA. The approval paves the way for the method to be deployed in U.S. healthcare facilities in place of device-specific program from manufacturers.

This new alternative standard, based on the American College of Radiology Digital Mammography Quality Control Manual, was found to meet the requirement of being “at least as effective in assuring quality mammography” as following the manufacturers’ quality control manuals.

The alternative method has been approved for use in all healthcare facilities with the requisite imaging systems.

Read the full news release from the FDA here.

John Hocter,

Digital Editor

With nearly a decade of experience in print and digital publishing, John serves as Content Marketing Manager. His professional skill set includes feature writing, content marketing and social media strategy. A graduate of The Ohio State University, John enjoys spending time with his wife and daughter, along with a number of surprisingly mischievous indoor cacti.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.